Cargando…
Experimental Antioxidant Therapy in Ataxia Telangiectasia
Ataxia telangiectasia (AT) is a rare genetic disorder characterized by immunodeficiency, early onset neurological degeneration, hypersensitivity to ionizing radiation and a high incidence of lymphoid cancers. The disease results from bi-allelic mutations in the AT mutated (ATM) gene involved in cell...
Autores principales: | Reliene, Ramune, Schiestl, Robert H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161695/ https://www.ncbi.nlm.nih.gov/pubmed/21892312 |
Ejemplares similares
-
Ataxia-telangiectasia: future prospects
por: Chaudhary, Mohammed Wajid, et al.
Publicado: (2014) -
Ataxia telangiectasia: a review
por: Rothblum-Oviatt, Cynthia, et al.
Publicado: (2016) -
Myoclonus in Ataxia–Telangiectasia
por: Termsarasab, Pichet, et al.
Publicado: (2015) -
Growth in ataxia telangiectasia
por: Natale, Valerie A. I., et al.
Publicado: (2021) -
Metabolic Stress and Mitochondrial Dysfunction in Ataxia-Telangiectasia
por: Subramanian, Goutham Narayanan, et al.
Publicado: (2022)